InMed Pharmaceuticals Inc. - Common Shares (NQ:INM)

1.350 +0.020 (+1.50%)

Delayed Quote Updated: 9:42 AM EDT, Oct 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about InMed Pharmaceuticals Inc. - Common Shares

< Previous 1 2 3 4 5 6 7 8 9

...

15 16 Next >

InMed’s (NASDAQ: INM) Latest Research Demonstrates Potential In Treating Alzheimer’s with a Rare Cannabinoid Analog

December 12, 2023

--News Direct--

Via News Direct

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

December 12, 2023

Checking out the biggest pre-market stock movers for Tuesday is the perfect way to get ready for another busy day of trading!

Via InvestorPlace

InMed's (NASDAQ: INM) Latest Research Demonstrates Potential In Treating Alzheimer's With A Rare Cannabinoid Analog ↗

December 11, 2023

When it comes to treating degenerative diseases like Alzheimer’s, much of the current focus is on addressing the symptoms rather than repairing and regenerating the damaged tissues and cells. Some...

Via Benzinga

InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Advancing INM-089 to Target Treatment of Age-Related Macular Degeneration

November 29, 2023

Via Investor Brand Network

Why Is InMed (INM) Stock Up 110% Today? ↗

October 24, 2023

Here's what investors in INM stock may want to watch, given the company's recent impressive early results from an Alzheimer's drug candidate.

Via InvestorPlace

TinyGemsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Q1 Fiscal 2024 Financial Results, Provides Business Update

November 14, 2023

Via Investor Brand Network

Topics Supply Chain

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

November 08, 2023

Pre-market stock movers are a hot topic on Wednesday and we're starting the morning with a breakdown of the biggest ones.

Via InvestorPlace

BioMedNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) to Present Phase 2 Study Results for INM-755 at 12th Annual WCI

November 02, 2023

Via Investor Brand Network

BioMedNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Secures $5.2M in Private Placement and Preferred Investment Option Offerings

October 27, 2023

Via Investor Brand Network

Why Owens Corning Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

October 25, 2023

Gainers Abri SPAC I, Inc. (NASDAQ: ASPA) shares climbed 127.1% to $28.39. Abri's stockholders approved its proposed business combination with DLQ.

Via Benzinga

TinyGemsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Enters Agreements for Private Placement, Preferred Investment Options

October 25, 2023

Via Investor Brand Network

EVGO Stock Slips as TD Cowen Downgrades EVgo ↗

October 25, 2023

EVgo stock is taking a beating on Wednesday as investors in the EV charging company deal with a downgrade and price cut.

Via InvestorPlace

Why Is BioXcel Therapeutics (BTAI) Stock Up 42% Today? ↗

October 25, 2023

BioXcel Therapeutics stock is rising on Wednesday as investors in BTAI stock react to results from an audit on a clinical trial.

Via InvestorPlace

Why Is InMed Pharmaceuticals (INM) Stock Down 25% Today? ↗

October 25, 2023

InMed Pharmaceuticals stock is falling on Wednesday after shares of INM underwent a massive rally on Tuesday alongside study results.

Via InvestorPlace

Why Microsoft Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket ↗

October 25, 2023

Gainers ReShape Lifesciences Inc. (NASDAQ: RSLS) shares surged 62.8% to $0.3348 in pre-market trading after gaining over 6% on Tuesday. ReShape Lifesciences recently announced pricing of $3.0 million...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

October 25, 2023

Pre-market stock movers are a hot topic on Wednesday and we're offering all the details that investors need to know about this morning.

Via InvestorPlace

Nasdaq Gains 100 Points; Coca-Cola Earnings Top Expectations ↗

October 24, 2023

U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining over 200 points on Tuesday. The Dow traded up 0.67% to 33,155.68 while the NASDAQ rose 0.78% to 13,120.31. The S&P...

Via Benzinga

Topics Stocks

Why Asbury Automotive Group Shares Are Trading Lower By Over 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

October 24, 2023

Gainers InMed Pharmaceuticals Inc. (NASDAQ: INM) shares climbed 169% to $1.56 after the company announced it selected a lead Alzheimer's drug candidate following proof-of-concept study data.

Via Benzinga

Crude Oil Down Over 2%; General Motors Posts Upbeat Earnings ↗

October 24, 2023

U.S. stocks traded slightly higher midway through trading, with the Dow Jones index gaining around 50 points on Tuesday. The Dow traded up 0.17% to 32,992.95 while the NASDAQ rose 0.06% to 13,023.65....

Via Benzinga

Topics Stocks

BioMedNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) to Advance INM-901 Following Positive Proof-of-Concept Results

October 24, 2023

Via Investor Brand Network

Why InMed Pharmaceuticals Stock Is Soaring Tuesday ↗

October 24, 2023

InMed Pharmaceuticals Inc (NASDAQ: INM) shares are trading higher Tuesday after the company said it selected a lead Alzheimer's drug candidate following positive proof-of-concept study data.

Via Benzinga

Dow Surges 250 Points; US Manufacturing PMI Tops Expectations ↗

October 24, 2023

U.S. stocks traded higher this morning, with the Dow Jones index gaining over 250 points on Tuesday. Following the market opening Tuesday, the Dow traded up 0.80% to 33,200.75 while the NASDAQ rose...

Via Benzinga

Topics Stocks

InMed Pharmaceuticals, A Cannabinoid-Focused Company, Sponsored Benzinga's Cannabis Capital Conference ↗

October 16, 2023

InMed Pharmaceuticals (NASDAQ: INM) is a global leader in researching, developing, manufacturing and commercializing rare cannabinoids and cannabinoid analogs.

Via Benzinga

Topics Cannabis

Cannabis Industry Report Highlights Positive Sentiment and Growth Potential at Benzinga Conference ↗

October 13, 2023

Discover key insights from the Benzinga Cannabis Conference, featuring strategies from top firms like MariMed, AYR & InMed!

Via Benzinga

Topics Cannabis

BioMedNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Releases FY 2023 Report, Shares Corporate Update

September 29, 2023

Via Investor Brand Network

This Clinical Stage BioPharma Is Seeing Solid Growth In Rare Cannabinoid Demand From The Health And Wellness Sector ↗

September 15, 2023

BayMedica, a rare cannabinoids supplier for the health and wellness sector acquired by InMed Pharmaceuticals (NASDAQ: INM) in 2021, is scaling up its manufacturing process to meet growing demand.

Via Benzinga

Topics Supply Chain

BioMedNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) to Present at H.C. Wainwright 25th Annual Global Investment Conference

September 07, 2023

Via Investor Brand Network

Cannabis Stock Gainers And Losers From August 25, 2023 ↗

August 25, 2023

Via Benzinga

Topics Cannabis

Marijuana Stock Movers For August 22, 2023 ↗

August 22, 2023

Via Benzinga

Topics Cannabis

Cannabis Stock Gainers And Losers From August 16, 2023 ↗

August 16, 2023

Via Benzinga

Topics Cannabis

< Previous 1 2 3 4 5 6 7 8 9

...

15 16 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.